Previous Close | 119.00 |
Open | 117.45 |
Bid | 113.40 |
Ask | 116.90 |
Strike | 200.00 |
Expire Date | 2024-01-19 |
Day's Range | 117.45 - 117.45 |
Contract Range | N/A |
Volume | |
Open Interest | 320 |
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Eli Lilly and...
Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.
Biotech giant Eli Lilly (NYSE: LLY) crushed the stock market last year, but the drugmaker is not starting off so well in 2023. It's too soon to tell how things will shape up for the rest of the year for Eli Lilly. Let's dig deeper into Eli Lilly's business and determine whether its shares are worth buying right now.